CORONA Remedies Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
28 Sep 2026Anchor Partners
Reg29(2)
Sale Open Market — 92,763
0.15%
0.32% No
28 Sep 2026Sepia Investments Limited
Reg29(2)
Sale Open Market — 2,485,476
4.06%
8.62% No
28 Sep 2026Sage Investment Trust
Reg29(2)
Sale Open Market — 51,641
0.08%
0.18% No
24 Jun 2026Sage Investment Trust
Reg29(2)
Sale Open Market — 90,087
0.15%
0.26% No
24 Jun 2026Anchor Partners
Reg29(2)
Sale Open Market — 161,861
0.26%
0.47% No
24 Jun 2026Sepia Investments Limited
Reg29(2)
Sale Open Market — 4,328,943
7.08%
12.68% No
19 Jun 2026Invesco Mutual Fund
Reg29(1)
Acquisition Open Market 289,017
0.47%
— 5.06% No
19 Jun 2026Invesco Mutual Fund
Reg29(1)
Acquisition Open Market 289,017
0.47%
— 5.06% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.